Experiment summary for ENCSR000EZQ

Summary

Status
released
Assay
ChIP-seq
Target
POLR2A
Biosample summary
Homo sapiens HepG2 treated with 2 μM pravastatin for 16 hours
Biosample Type
cell line
Replication type
isogenic
Description
POLR2A ChIP-seq on human HepG2 treated with pravastatin
Treatments
2 μM pravastatin (CHEBI:63618) for 16 hour
Nucleic acid type
DNA
Lysis method
see document
Extraction method
see document
Fragmentation method
see document
Size selection method
see document
Strand specificity
Non-strand-specific
Controls

Attribution

ENCODE2 project
Lab
Sherman Weissman, Yale
Award
U54HG004558 (Michael Snyder, Stanford)
Project
ENCODE
Date submitted
December 2, 2010
Date released
October 29, 2011
Tags
Search for all Experiment with internal tag ENCYCLOPEDIAv4

Isogenic replicates

Isogenic replicateTechnical replicateSummaryBiosampleAntibodyLibrary
11HepG2 cell line treated with 2 μM pravastatin for 16 hoursENCBS712AAAENCAB000AOCENCLB723GVG
21HepG2 cell line treated with 2 μM pravastatin for 16 hoursENCBS712AAAENCAB000AOCENCLB723GVD
31HepG2 cell line treated with 2 μM pravastatin for 16 hoursENCBS712AAAENCAB000AOCENCLB723GVC